Osaic Holdings’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22 Sell
49
-14
-22% -$8 ﹤0.01% 7990
2026
Q2
$41 Hold
63
– – ﹤0.01% 7887
2026
Q1
$45 Buy
63
+8
+15% +$7 ﹤0.01% 7685
2025
Q4
$73 Buy
55
+41
+293% +$41 ﹤0.01% 7667
2025
Q3
$10 Hold
14
– – ﹤0.01% 7860
2025
Q2
$12 Sell
14
-1
-7% -$1 ﹤0.01% 7679
2025
Q1
$26 Hold
15
– – ﹤0.01% 7333
2024
Q4
$43 Sell
15
-13
-46% -$47 ﹤0.01% 7303
2024
Q3
$104 Buy
28
+14
+100% +$61 ﹤0.01% 7246
2024
Q2
$66 Hold
14
– – ﹤0.01% 7286
2024
Q1
$104 Sell
14
-1
-7% -$6 ﹤0.01% 7029
2023
Q4
$121 Buy
15
+14
+1,400% +$88 ﹤0.01% 7097
2023
Q3
$5 Sell
1
-14
-93% -$143 ﹤0.01% 7356
2023
Q2
$163 Hold
15
– – ﹤0.01% 7236
2023
Q1
$1.03K Hold
15
– – ﹤0.01% 6938
2022
Q4
$1K Sell
15
-1
-6% -$101 ﹤0.01% 6987
2022
Q3
$1K Hold
16
– – ﹤0.01% 7094
2022
Q2
$2K Buy
16
+14
+700% +$3.32K ﹤0.01% 6950
2022
Q1
$0 Hold
2
– – ﹤0.01% 7536
2021
Q4
$0 Hold
2
– – ﹤0.01% 7604
2021
Q3
$2K Hold
2
– – ﹤0.01% 6898
2021
Q2
$2K Hold
2
– – ﹤0.01% 6762
2021
Q1
$3K Buy
+2
New +$2.91K ﹤0.01% 6415

Other funds holding YCBD

Osaic Holdings's YCBD Position: Q3 2026 in Review

Osaic Holdings reduced its cbdMD (YCBD) stake by 22% in Q3 2026, selling an estimated $8 and leaving 49 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #7990.

Osaic Holdings first reported a position in YCBD in Q1 2021 and has held it in 23 quarters since. The position peaked at $3K in Q1 2021. 15 funds tracked by Wall St. Rank hold YCBD as of Q3 2026.

  • Osaic Holdings held 49 shares of cbdMD worth $22 as of Q3 2026.
  • Osaic Holdings sold 14 cbdMD shares in Q3 2026, an estimated $8.
  • cbdMD made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #7990 holding.
  • Osaic Holdings first reported a position in cbdMD in Q1 2021 and has held it in 23 quarters since.
  • Osaic Holdings's cbdMD position peaked at $3K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held cbdMD as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.